-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Gyre Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Gyre Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was $4.23M, a 66.8% decline year-over-year.
- Gyre Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$76.1M, a 4017% decline year-over-year.
- Gyre Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$67.2M, a 831% decline from 2022.
- Gyre Therapeutics, Inc. annual Operating Income (Loss) for 2022 was $9.2M.
- Gyre Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$87.9M, a 53.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)